Not applicableStudy completedNCT03517917What this trial is testingProspective Tissue Collection Research ProtocolWho this might be right forSolid Tumor AstraZeneca 221
Very early researchEnrolling By InvitationNCT07316361What this trial is testingGYNORYLAQ™-VLINIVAL™: Ψ-Guided Personalized Neoantigen Peptide Vaccine for High-Risk Endometrial CancerWho this might be right forEndometrial CarcinomaEndometrial Carcinoma Stage III Biogenea Pharmaceuticals Ltd. 40
Not applicableUnknownNCT06141369What this trial is testingTreatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)Who this might be right forAdrenal Cortical CarcinomaMedullary Thyroid CancerThymic Neuroendocrine Carcinoma+1 more Shanghai Jiao Tong University School of Medicine 21
Early research (Phase 1)UnknownNCT03558945What this trial is testingClinical Trial on Personalized Neoantigen Vaccine for Pancreatic TumorWho this might be right forPancreatic Tumor Anda Biopharmaceutical Development (Shenzhen) Co., Ltd. 30
Early research (Phase 1)UnknownNCT04487093What this trial is testingClinical Study of Neoantigen Vaccine Combined With Targeted Drugs in the Treatment of Non-small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer First Hospital of Shijiazhuang City 20
Testing effectiveness (Phase 2)Study completedNCT03357757What this trial is testingAvelumab With Valproic Acid in Virus-associated CancerWho this might be right forCancer That is Associated With a Chronic Viral Infectionp16 Positive SCCHNSquamous Cell Carcinoma of the Cervix+5 more AHS Cancer Control Alberta 39
Testing effectiveness (Phase 2)UnknownNCT03171220What this trial is testingNeoantigen Reactive T Cells Combined With SHR-1210 for Chinese Patients With Advanced Refractory Solid TumorsWho this might be right forAdvanced Malignant Solid Tumor The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 40
Not applicableUnknownNCT05192460What this trial is testingSafety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer, Esophageal Cancer and Liver CancerWho this might be right forGastric CancerEsophageal CancerLiver Cancer jianming xu 30
Not applicableNo Longer AvailableNCT03914872What this trial is testingExpanded Access Neoantigen Vaccine in Solid TumorsWho this might be right forSolid Tumor, Adult Washington University School of Medicine
Large-scale testing (Phase 3)Looking for participantsNCT06623422What this trial is testingPembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Who this might be right forCarcinoma, Non-Small-Cell Lung Merck Sharp & Dohme LLC 680
Testing effectiveness (Phase 2)Ended earlyNCT04785365What this trial is testingLong-Term Follow-Up Study of Patients Receiving ATL001Who this might be right forMelanomaAdvanced Non Small Cell Lung Cancer Achilles Therapeutics UK Limited 1
Early research (Phase 1)Not Yet RecruitingNCT04266730What this trial is testingTrial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With PembrolizumabWho this might be right forSquamous Cell Lung CancerSquamous Non-small Cell Lung CancerSquamous Cell Carcinoma of Head and Neck UNC Lineberger Comprehensive Cancer Center 6
Early research (Phase 1)Looking for participantsNCT02287428What this trial is testingPersonalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBMWho this might be right forGlioblastoma Dana-Farber Cancer Institute 56
Early research (Phase 1)UnknownNCT03662815What this trial is testingClinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant TumorWho this might be right forAdvanced Malignant Solid Tumor Sir Run Run Shaw Hospital 30
Not applicableLooking for participantsNCT06751914What this trial is testingNeoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line TreatmentWho this might be right forColorectal Cancer (CRC) The First Affiliated Hospital of Nanchang University 10
Testing effectiveness (Phase 2)UnknownNCT04340401What this trial is testingTotal Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on NeoantigenWho this might be right forRectal Cancer Peking University Cancer Hospital & Institute 25
Testing effectiveness (Phase 2)Study completedNCT04364230What this trial is testingMelanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma)Who this might be right forMelanomaOcular MelanomaUveal Melanoma Craig L Slingluff, Jr 22
Early research (Phase 1)Looking for participantsNCT06026774What this trial is testingClinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System NeoplasmsWho this might be right forDigestive System Neoplasms Sir Run Run Shaw Hospital 20
Early research (Phase 1)Ended earlyNCT03199040What this trial is testingNeoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care TherapyWho this might be right forTriple Negative Breast CancerTriple Negative Breast NeoplasmsTNBC - Triple-Negative Breast Cancer+1 more Washington University School of Medicine 18
Early research (Phase 1)UnknownNCT05317325What this trial is testingA Translational Study of Tumor Antigen-pulsed DC Vaccine for ESCCWho this might be right forEsophageal Squamous Cell Carcinoma Sichuan University 20